The Intracept Procedure is a minimally invasive, outpatient procedure for patients with vertebrogenic pain. The procedure targets a specific nerve within the vertebra called the basivertebral nerve and has been shown to improve function and relieve pain long-term. The procedure is implant-free, preserving future treatment options for other spine conditions.
Relievant was founded in 2006. After a successful Pilot Study in 2010, we sponsored the SMART Trial, a Level I, randomized double blind sham-controlled trial that led to FDA clearance.
This was followed by the INTRACEPT Study – a Level I, prospective, randomized clinical study comparing the Intracept Procedure to the current standard of care for patients with chronic vertebrogenic low back pain.
These studies demonstrated safety, effectiveness and durability of improvements in pain and function for patients treated with the Intracept Procedure. Results were reproducible across both Level I RCTs and in a prospective, single-arm cohort study in a typical spine setting. Additionally, four independent systematic reviews have been published to validate the Intracept Procedure’s effectiveness as a treatment for vertebrogenic low back pain.
Today, physicians trained to perform the Intracept Procedure are seeing similar life-changing results in vertebrogenic pain patients in their own practices with –validating the important role of the Intracept Procedure in the CLBP care pathway.